Leuprorelin Acetate Microspheres for Injection Instructions

Instructions for Leuprorelin Acetate Microspheres for Injection (Yina Tong) used to treat endometriosis, uterine fibroids, breast cancer, prostate cancer…


Leuprorelin Acetate Microspheres for Injection Instructions - cover page
Brand
Ferring
Document type
User Manual
Language
Chinese
Pages
21
File format
PDF
File size
947 KB
Published
17 October, 2026
Updated
17 October, 2026
MD5 checksum
B60D263B84FEAF821847DB6EC80F9745

About this manual

This document provides the official instructions for use of Leuprorelin Acetate Microspheres for Injection, marketed under the trade name Yina Tong. It details the active ingredient, chemical composition, and physical characteristics of the sterile powder intended for injection.

The manual outlines specific indications including endometriosis, uterine fibroids, estrogen receptor-positive premenopausal breast cancer, prostate cancer, and central precocious puberty. It provides detailed dosage instructions based on the condition being treated (e.g., 3.75mg every 4 weeks for endometriosis) and includes step-by-step preparation methods for both vial and prefilled syringe formats. This manual is written in Chinese.

What's inside

  • 药品名称
  • 成份
  • 性状
  • 适应症
  • 规格
  • 用法用量
  • 不良反应
  • 禁忌
  • 注意事项

Frequently asked questions

What is the recommended dosage for endometriosis?

Adults typically receive 3.75mg subcutaneously every 4 weeks, starting on days 1-5 of the menstrual cycle.

How should the vial specification be prepared before use?

Before administration, an additional 1ml of injection solvent must be used to fully suspend the drug in the bottle, taking care not to create foam.

Download PDF (947 KB)